Company: PETVW
Filing Date: 2025-02-14
Form Type: 10-Q
Source: 0001493152-25-006783
Chunk: 30

Company: PetVivo Holdings, Inc.
Filing Date: 2025-02-14
Form: 10-Q
Item: Part I, Item 1
Chunk 30
---
 common stock available and reserved to be issued under the Amended Plan is 3,000,000 shares, but
includes the following limits:

●
the maximum aggregate number of shares of Common Stock granted as an Award to any Non-Employee Director in any one Plan Year will be
10,000 shares; provided that such limit will not apply to any election of a Non-Employee Director to receive shares of Common Stock in
lieu of all or a portion of any annual Board, committee, chair or other retainer, or any meeting fees otherwise payable in cash.

Awards
can be granted for no cash consideration or for any cash and other consideration as determined by the Committee. Awards may provide that
upon the grant or exercise thereof, the holder will receive cash, shares of PetVivo common stock, other securities or property, or any
combination of these in a single payment, installments, or on a deferred basis. The exercise price per share of any stock option and
the grant price of any stock appreciation right may not be less than the fair market value of PetVivo common stock on the date of grant.
The term of any award cannot be longer than ten years from the date of grant. Awards will be adjusted in the event of a stock dividend
or other distribution, recapitalization, forward or reverse stock split, reorganization, merger or other business combination, or similar
corporate transaction, in order to prevent dilution or enlargement of the benefits or potential benefits provided under the Amended Plan.

The
Amended Plan permits the following types of awards: stock options, stock appreciation rights, restricted stock awards, restricted stock
units, deferred stock units, performance awards, non-employee director awards, other stock-based awards, and dividend equivalents.

    21

Common
Stock

For
the nine months ended December 31, 2024, the Company issued 4,218,164 shares and canceled 25,000 shares of common stock as follows:

    i)
    1,889,434 shares in connection
    with the sale of stock in April and May 2024 in exchange for proceeds of $1,322,600 at a price of $0.70 per share;

    ii)
    430,798 shares in April
    2024 in connection with the conversion of a convertible note plus interest in exchange for proceeds of $301,558 at a price of $0.70
    per share;

    iii)
    320,000 shares